Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02917720
Title 2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients (NAUT)
Acronym NAUT
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European LeukemiaNet
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | DEU


No variant requirements are available.